Civilization Ventures is a venture capital firm focused on healthcare innovations. They back inspired founders solving essential problems in healthcare.

Civilization Ventures

浙商创投股份有限公司 is involved in investment activities, particularly in ventures related to technology and healthcare startups, as evidenced by its investment in 太美医疗科技 and other listed enterprises.

浙商创投股份有限公司

Medical Devices Venture is a holding company that develops a portfolio of investments in Med Tech start-ups. The aim is to combine the expertise of researchers in hospital and university settings with industrialization and commercialization capabilities.

Medical Devices Venture

At CV, we champion visionary founders tackling the most critical challenges in biology and healthcare. With a portfolio worth $9.7B, encompassing 64 companies and 9 successful exits, we provide the capital and resources necessary for innovators to thrive.

Pillo Health

Lemonaid Health

Rocket Pharmaceuticals

Singular Bio

We're humbled to announce the acquisition of Civilization Ventures portfolio company Fluent BioSciences Inc. by Illumina - our 10th exit in the fund!

Our thanks to the founders, executives and visionaries behind Fluent, including our co-investors at Samsara (Mike Dybbs) and Illumina VC (Wouter Meuleman): Sepehr Kiani, Kristina Fontanez, William (Bill) Hyun, Adam Abate, Brian McKernan, Gary Zweiger and many others. 

On a personal note, this marks my 3rd exit to Illumina as an investor/executive, and I'm humbled that our fund is able to play a role in building cutting-edge life sciences tools that are driving the future of biological innovation.

We are thrilled to announce the acquisition of our portfolio company, Fluent BioSciences Inc., by Illumina, marking the 10th exit for our fund.

Congratulations to the founders, executives and visionaries behind Fluent, including Sepehr Kiani and Brian McKernan.

🔈 CV Fireside Chat Series: Sourcing Innovation

We want to extend a heartfelt thank you to our speakers for the second installment of the "Sourcing Innovation" series, which focused on the journey of two CEOs who have successfully spun out their PhD projects.  

Shakked Halperin, PhD: CEO and Founder of Replace Therapeutics (Exited) and Rewrite Therapeutics (Exited), spun out of University of California, Berkeley

Marco Lobba, Ph.D.: CEO and Co-Founder of CatenaBio, spun out of University of California, Berkeley

In the Sourcing Innovation series, we aim to broaden the discussion around academic entrepreneurship by exploring the spin-out process from two crucial perspectives: the PIs who lay the groundwork and the PhD trainees-turned-CEOs who bring these innovations to market.

🇺🇸 Happy early 4th of July from our team at CV 🇺🇸 

If you are interested in learning more about the transformative potential of Generative AI in healthcare and life sciences, hear our founding GP Shahram Seyedin-Noor share his views as part of the Talk Gen AI panel at Swissnex below. 

#generativeai 

https://lnkd.in/gCmUzFgM

🔈 CV Fireside Chat Series: Sourcing Innovation

We want to extend a heartfelt thank you to our speakers for the first installment of the "Sourcing Innovation" series. This segment delves into the intricate process of spinning out technologies from academia, providing invaluable insights from our distinguished advisors:

Hani Goodarzi: Core Investigator Arc Institute, Associate Professor University of California, San Francisco

David Schaffer: Director Bakar Labs/QB3, Distinguished professor University of California, Berkeley

In the Sourcing Innovation series, we aim to broaden the discussion around academic entrepreneurship by exploring the spin-out process from two crucial perspectives: the PIs who lay the groundwork and the PhD trainees-turned-CEOs who bring these innovations to market.

Metric
Company Name	Civilization Ventures	浙商创投股份有限公司	Medical Devices Venture
Symbol
MSH ID	COM:CIVILIZATIONVENTURES	CN:COM:ZSVC	COM:MEDICALDEVICESVENTURE
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Financial Services & Finance	Healthcare & Health Services
Industry	Venture Capital	Venture Capital	Medical Devices
Country	US	CN	FR
Stage
Employee Count	15
Website	civilizationventures.com	zsvc.com.cn	medicaldevicesventure.com
LinkedIn	civilizationventures	%E6%B5%99%E5%95%86%E5%88%9B%E6%8A%95%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8	medical-devices-venture
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.04K	78
Web Traffic Growth	7.64
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CIVI

COM:CIVILIZATIONVENTURES

Civilization Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue